cdmo.directory
← Compare landing

AGC Biologics vs Asimov

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/agcbio/asimov

CategoryAGC BiologicsAsimov
Listed sitecdmocdmo
SummaryGlobal CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.Asimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.
Services
  • Technology Transfer
  • Process Development
  • Cell-Line Development
  • CMC Analytical Development
  • Formulation Development
  • Quality Control Testing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • CMC Regulatory Submission Support
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • mRNA Manufacturing
  • Biologics Development & Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • CMC Analytical Development
  • Technology Transfer
  • Lentiviral Vector Manufacturing
  • AAV Manufacturing
  • Viral Vector Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Process Development
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Gene Therapy
  • Cell Therapy
  • mRNA
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Seattle, Washington, USA
  • Copenhagen, Copenhagen, Denmark
  • Heidelberg, Heidelberg, Germany
  • Milan, Milan, Italy
  • Chiba, Chiba, Japan
  • Yokohama, Yokohama, Japan
  • Headquarters, Boston, MA, USA
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.